Concepedia

B. Thürlimann

BT

Statistics

Publications

4

Citations

139

H-Index

4

Active since

1997

Affiliations

Kantonsspital St. Gallen(Current)

B. Thürlimann is an author at Kantonsspital St. Gallen specializing in medicine, pharmacotherapy, and oncology.

Top concepts

MedicineOncologyMenopauseGynecologyBreast CancerClinical TrialsPharmacotherapyHealthOrthopedicsOsteoporosis

Publications per year

1997–2014

4

Publications

4

Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)

B. Thürlimann, M. Castiglione, S.F. Hsu-Schmitz et al. · European Journal of Cancer · 1997 · 67 citations

Breast Oncology, Medicine, Pharmacology +10

Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy

R. Rizzoli, D. Thiébaud, Nigel Bundred et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 47 citations · Full text

Symptoms of endocrine treatment and outcome: A retrospective analysis of the monotherapy arms of the BIG 1-98 trial.

J. Huober, B. F. Cole, Jian Wu et al. · Journal of Clinical Oncology · 2011 · 13 citations

Breast Oncology, Arthralgia/myalgia Symptoms, Carpal Tunnel Syndrome +23

Prevention of Symptomatic Skeletal Events with Denosumab Administered Every 4 Weeks Versus Every 12 Weeks–A Non-Inferiority Phase III Trial: Sakk 96/12 - Reduse

Arnoud J. Templeton, Lukas Stalder, L. Albiges Sauvin et al. · Annals of Oncology · 2014 · 12 citations · Full text

Bone Disease, Rheumatology, Sakk 96/12 +5

1–4 of 4